These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1096756)

  • 1. Alterations in T- and B-cells in human disease states.
    Williams RC; Messner RP
    Annu Rev Med; 1975; 26():181-92. PubMed ID: 1096756
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical significance of lymphocyte populations].
    Flad HD
    Med Klin; 1979 Aug; 74(34):1199-206. PubMed ID: 388169
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymphocyte surface markers in lymphoproliferative disorders.
    Aiuti F; Lacava V; Fiorilli M; Ciarla MV
    Acta Haematol; 1973; 50(5):275-83. PubMed ID: 4202631
    [No Abstract]   [Full Text] [Related]  

  • 4. [Data obtained by the study of membrane markers of human lymphoid cells in disease].
    Seligmann M; Preud'homme JL; Brouet JC
    Schweiz Med Wochenschr; 1977 Dec; 107(49):1798-807. PubMed ID: 337473
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on antilymphocyte antibodies in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Winchester RJ; Winfield JB; Fu SM; Wernet P; Kunkel HG
    Rheumatology; 1975; 6():209-14. PubMed ID: 1081726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying and enumerating human T and B lymphocytes. A review of techniques, problems, and progress in clinical studies.
    Dwyer JM
    Prog Allergy; 1976; 21():178-260. PubMed ID: 794886
    [No Abstract]   [Full Text] [Related]  

  • 7. [Behavior of thymus-dependent and bursa-dependent lymphocytes (T and B) in some lymphoproliferative diseases].
    Barabino A; Di Benedetto G; Franceschini R; Indiveri F; Puppo F; Soldà AM
    Boll Soc Ital Biol Sper; 1975 Nov; 51(22):1612-6. PubMed ID: 1084753
    [No Abstract]   [Full Text] [Related]  

  • 8. [Surface marker of T- and B-leukemic cells and classification of lymphocyte proliferative neoplasms].
    Kikuchi K; Ishii Y; Koshiba H
    Nihon Rinsho; 1976 May; 34(5):900-11. PubMed ID: 789939
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum migration-inhibitory activity in patients with lymphoproliferative diseases.
    Cohen S; Fisher B; Yoshida T; Bettigole RE
    N Engl J Med; 1974 Apr; 290(16):882-6. PubMed ID: 4593612
    [No Abstract]   [Full Text] [Related]  

  • 10. [T and B lymphocytes in humans. Lymphocytes with membrane immunoglobulins in normal and pathological conditions].
    Aiuti F; Lacava V; D'Asero C; Ciarla MV; D'Amelio R; Fiorilli M
    Recenti Prog Med; 1973 Feb; 54(2):124-51. PubMed ID: 4541383
    [No Abstract]   [Full Text] [Related]  

  • 11. [Present status of immunopathogenesis of rheumatoid arthritis].
    Orlovskaia GV
    Vopr Revm; 1977; (4):60-7. PubMed ID: 343386
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell-surface modifications of normal human peripheral lymphocytes induced by lymphocytotoxic sera of patients with systemic lupus erythematosus and Hodgkin's disease, studied by scanning electron microscopy.
    Del Giacco GS; Riva A; Loy M; Batzella MG; Cengiarotti L; Leone AL; Locci F; Murru V
    Haematologica; 1979 Apr; 64(2):148-58. PubMed ID: 112006
    [No Abstract]   [Full Text] [Related]  

  • 13. Interactions of T-and B-lymphocytes and macrophages in recovery from virus infections.
    Allison AC
    Proc R Soc Med; 1973 Dec; 66(12):1151-4. PubMed ID: 4599617
    [No Abstract]   [Full Text] [Related]  

  • 14. [Surface markers of peripheral blood T- and B-lymphocytes in patients with rheumatoid diseases].
    Stankaitene DI; Redaitene EI; Rulis AK; Ianulevichiute NA
    Ter Arkh; 1981; 53(7):6-11. PubMed ID: 7027511
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppressor cells in neoplastic disease.
    Broder S; Muul L; Waldmann TA
    J Natl Cancer Inst; 1978 Jul; 61(1):5-11. PubMed ID: 353295
    [No Abstract]   [Full Text] [Related]  

  • 16. [T-and B-lymphocytes in lymphoproliferative syndromes].
    Girard JP; Fernandes B
    Schweiz Med Wochenschr; 1975 Sep; 105(37):1174-9. PubMed ID: 814616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological diagnosis of rheumatoid arthritis and systemic lupus erythematosus.
    Wager O
    Ann Clin Res; 1975 Jun; 7(3):168-82. PubMed ID: 1103712
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hematologic diseases and T-cell dysfunction--multiple myeloma, T-cell leukemia, and aplastic anemia].
    Takatsuki K; Uchiyama T; Nagai K
    Nihon Rinsho; 1978; 36(5):977-84. PubMed ID: 353332
    [No Abstract]   [Full Text] [Related]  

  • 19. Lymphocytotoxic antibodies.
    DeHoratius RJ
    Prog Clin Immunol; 1980; 4():151-54. PubMed ID: 6992218
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of a suppressor-cell leukemia. Evidence for the requirement of an interaction of two T cells in the development of human suppressor effector cells.
    Broder S; Poplack D; Whang-Peng J; Durm M; Goldman C; Muul L; Waldmann TA
    N Engl J Med; 1978 Jan; 298(2):66-72. PubMed ID: 304175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.